Linh M. Tran
0000-0001-8597-643X
Publication & Citation Trends
Publications
0 total
Abstract B090: ATRA reprograms neutrophils in the tumor microenvironment and overcomes resistance to immune checkpoint inhibition in murine models of LKB1-deficient non-small cell lung cancer
Cited by 0
Semantic Scholar
Abstract B009: Developing a platform for CEA-directed CAR-NK cells expressing IL-15 and CCL21 for the treatment of non-small cell lung cancer
Cited by 0
Semantic Scholar
Abstract B092: Mechanisms of PARP7 inhibition-induced tumor cell death: A novel therapeutic for non-small cell lung cancer with tumor-intrinsic and immune-dependent pathways
Cited by 0
Semantic Scholar
Abstract B089: Assessing integrin αvβ5 as a therapeutic target suppressing tumor progression and enhancing immune responses in non-small cell lung cancer
Cited by 0
Semantic Scholar
Abstract B068: A novel murine model for interrogating immune response to tumor heterogeneity in non-small cell lung cancer
Cited by 0
Semantic Scholar
Abstract 4266: Evaluation of integrin alpha v beta 5 as a novel target for non-small cell lung cancer via tumor intrinsic and host immune regulation
Cited by 0
Semantic Scholar
Abstract 6751: In situ vaccination with Flt3l gene modified CD103+ type 1 conventional dendritic cells synergizes with anti-PD-1 checkpoint blockade in murine models of non-small cell lung cancer
Cited by 0
Semantic Scholar
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer OA
Cited by 83
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(56)
Cancer Genomics and Diagnostics
(42)
Immunotherapy and Immune Responses
(34)
Cancer Cells and Metastasis
(27)
Ferroptosis and cancer prognosis
(25)
Affiliations
University of Bern
Texas Tech University
Vietnam National University Ho Chi Minh City
University of Copenhagen
Merck & Co., Inc., Rahway, NJ, USA (United States)